Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000279 · ClinicalTrials.gov registry record · Phase 2
Novel Medications for Opiate Detoxification - 4
A Phase 2 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000279: Completed Phase 2 study, sponsored by Yale University.
NCT00000279 is a Phase 2 study that has completed, run by Yale University. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000279, a Phase 2 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to evaluate novel medications for opiate detoxification.
Interventions
- DRUG Clonidine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1994-09 |
| Est. Completion | 1999-08 |
| Phase | Phase 2 |
What the finished NCT00000279 record still lists
NCT00000279 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Clonidine is the first listed.
NCT00000279 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000279 about?
NCT00000279 is a clinical study titled "Novel Medications for Opiate Detoxification - 4". The purpose of this study is to evaluate novel medications for opiate detoxification.
What is the current status of trial NCT00000279?
This trial is currently completed. It is a Phase 2 study. The study started on 1994-09. Estimated completion is 1999-08.
What interventions are being tested in trial NCT00000279?
The interventions under investigation include: Clonidine (DRUG).
Who is sponsoring clinical trial NCT00000279?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia